Quest PharmaTech Inc. (TSXV:QPT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
Jul 17, 2025, 4:00 PM EDT
33.33%
Market Cap5.92M
Revenue (ttm)n/a
Net Income (ttm)-244.66K
Shares Out169.13M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume29,075
Open0.0400
Previous Close0.0400
Day's Range0.0400 - 0.0400
52-Week Range0.0200 - 0.0600
Beta-0.13
RSI49.81
Earnings DateSep 22, 2025

About Quest PharmaTech

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Ragupathy Madiyalakan
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol QPT
Full Company Profile

Financial Performance

Financial Statements

News

Quest PharmaTech Announces Opposition to OQPBIOM’s Acquisition of AdBioTech

EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) — Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of...

5 weeks ago - Financial Post

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality o...

5 weeks ago - GlobeNewsWire